ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE;DAIICHI SANKYO COMPANY, LIMITED
发明人:
Yoshihisa YAMANO,Natsumi UEDA,Kazushi ARAKI
申请号：
US16477286
公开号：
US20190343816A1
申请日:
2018.01.18
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides a pharmaceutical composition containing an inhibitor selected from the group consisting of an EZH1 inhibitor, an EZH2 inhibitor and an EZH1/2 dual inhibitor as an active ingredient, for use in treating HTLV-1-associated myelopathy. The present invention provides a pharmaceutical composition for use in treating HTLV-1-associated myelopathy, containing a 1,3-benzodioxole derivative or a pharmaceutically acceptable salt thereof.
